Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Auditor change
Appointed director
Quarterly results
Director departure
|
|
CAPRICOR THERAPEUTICS, INC. (CAPR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
4
| Auwaerter Paul Gisbert (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Bought 5,000 shares
@ $2.84, valued at
$14.2k
|
|
| 10/06/2023 |
4
| Musket David B (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Bought 2,500 shares
@ $2.9, valued at
$7.3k
|
|
| 08/16/2023 |
4
| Litvack Frank (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 20,748 shares
@ $1.39, valued at
$28.8k
Paid exercise price by delivering 4,364 shares
@ $6.61, valued at
$28.8k
Exercised 20,748 options to buy
@ $0 |
|
| 07/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/13/2023 |
4
| Auwaerter Paul Gisbert (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 115,000 options to buy
@ $4.47, valued at
$514.1k
|
|
| 07/13/2023 |
3
| Auwaerter Paul Gisbert (Director) has filed a Form 3 on CAPRICOR THERAPEUTICS, INC. |
| 05/16/2023 |
4
| Marban Linda (CEO) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 41,497 options to buy
@ $1.39, valued at
$57.7k
|
|
| 04/27/2023 |
4
| Avat Xavier (Former CBO) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Sold 14,772 shares
@ $64258, valued at
$949.2M
|
|
| 02/23/2023 |
4
| Manzo Louis (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 1,401 shares
@ $1.39, valued at
$1.9k
Disposed/sold 452 shares
@ $4.31, valued at
$1.9k
Exercised 1,401 options to buy
@ $0 |
|
| 02/23/2023 |
4
| Litvack Frank (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 14,027 shares
@ $1.39, valued at
$19.5k
Paid exercise price by delivering 4,524 shares
@ $4.31, valued at
$19.5k
Exercised 14,027 options to buy
@ $0 |
|
| 01/06/2023 |
4/A
| Sabar Karimah Es (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 3,560 options to buy
@ $3.85, valued at
$13.7k
|
|
| 01/05/2023 |
4
| Sabar Karimah Es (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 37,770 options to buy
@ $3.85, valued at
$145.4k
Granted 19,000 options to buy
@ $3.85, valued at
$73.2k
|
|
| 01/05/2023 |
4
| Musket David B (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 37,770 options to buy
@ $3.85, valued at
$145.4k
Granted 16,620 options to buy
@ $3.85, valued at
$64k
Granted 19,000 options to buy
@ $3.85, valued at
$73.2k
|
|
| 01/05/2023 |
4
| Manzo Louis (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 37,770 options to buy
@ $3.85, valued at
$145.4k
Granted 7,120 options to buy
@ $3.85, valued at
$27.4k
Granted 19,000 options to buy
@ $3.85, valued at
$73.2k
|
|
| 01/05/2023 |
4
| DUNBAR GEORGE W JR (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 37,770 options to buy
@ $3.85, valued at
$145.4k
Granted 8,310 options to buy
@ $3.85, valued at
$32k
Granted 19,000 options to buy
@ $3.85, valued at
$73.2k
|
|
| 01/05/2023 |
4
| Litvack Frank (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 185,000 options to buy
@ $3.85, valued at
$712.3k
|
|
| 01/05/2023 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 37,770 options to buy
@ $3.85, valued at
$145.4k
Granted 11,870 options to buy
@ $3.85, valued at
$45.7k
Granted 19,000 options to buy
@ $3.85, valued at
$73.2k
|
|
| 01/05/2023 |
4
| Marban Linda (CEO) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 135,000 options to buy
@ $3.85, valued at
$519.8k
|
|
| 01/05/2023 |
4
| Krasney Karen (EVP, GENERAL COUNSEL) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 80,000 options to buy
@ $3.85, valued at
$308k
Granted 11,878 options to buy
@ $3.85, valued at
$45.7k
|
|
| 01/05/2023 |
4
| Bergmann Anthony (CFO) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 85,000 options to buy
@ $3.85, valued at
$327.3k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Avat Xavier (CHIEF BUSINESS OFFICER) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Bought 1,500 shares
@ $3.7619, valued at
$5.6k
Bought 1,000 shares
@ $3.68, valued at
$3.7k
|
|
| 07/01/2022 |
4
| Musket David B (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Sold 28,215 shares
@ $3.77, valued at
$106.4k
Exercised 10,796 shares
@ $1.39, valued at
$15k
Exercised 1,401 options to buy
@ $0
Exercised 4,750 options to buy
@ $0
Exercised 4,645 options to buy
@ $0 |
|
| 06/29/2022 |
4
| Musket David B (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Sold 17,775 shares
@ $4.44, valued at
$78.9k
|
|
| 05/26/2022 |
4
| Avat Xavier (CHIEF BUSINESS OFFICER) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Granted 370,000 options to buy
@ $3.46, valued at
$1.3M
|
|
| 05/26/2022 |
3
| Avat Xavier (CHIEF BUSINESS OFFICER) has filed a Form 3 on CAPRICOR THERAPEUTICS, INC. |
| 04/01/2022 |
4
| Manzo Louis (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 27,904 shares
@ $1.39, valued at
$38.8k
Paid exercise price by delivering 11,309 shares
@ $3.43, valued at
$38.8k
Exercised 15,455 options to buy
@ $0
Exercised 12,449 options to buy
@ $0 |
|
| 03/31/2022 |
4
| DUNBAR GEORGE W JR (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 15,455 shares
@ $1.39, valued at
$21.5k
Paid exercise price by delivering 6,300 shares
@ $3.41, valued at
$21.5k
Exercised 15,455 options to buy
@ $0 |
|
| 03/09/2022 |
4
| COLLIER EARL M JR (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Exercised 15,455 shares
@ $1.39, valued at
$21.5k
Exercised 15,455 options to buy
@ $0 |
|
| 01/04/2022 |
4
| Litvack Frank (Director) has filed a Form 4 on CAPRICOR THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 67,552 shares
@ $3.18, valued at
$214.8k
Exercised 154,543 options to buy
@ $1.39, valued at
$214.8k
Granted 252,250 options to buy
@ $3.18, valued at
$802.2k
|
|
|
|
|